Triple artemisinin-containing combination anti-malarial treatments should be implemented now to delay the emergence of resistance
© 2019 The Author(s). Resistance threatens all our currently available anti-malarial drugs. Triple artemisinin-containing combination anti-malarial treatments (TACTs) combine an artemisinin derivative with two slowly eliminated partner drugs. TACTs are undergoing large-scale trials. If they prove sa...
Saved in:
Main Author: | Nicholas J. White |
---|---|
Other Authors: | Mahidol University |
Format: | Review |
Published: |
2020
|
Subjects: | |
Online Access: | https://repository.li.mahidol.ac.th/handle/123456789/51004 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Mahidol University |
Similar Items
-
Is triple artemisinin-based combination therapy necessary for uncomplicated malaria?
by: Rob W. van der Pluijm, et al.
Published: (2022) -
The impact of anti-malarial markets on artemisinin resistance: perspectives from Burkina Faso
by: Guissou R.M.
Published: (2023) -
Modulating effects of plasma containing anti-malarial antibodies on in vitro anti-malarial drug susceptibility in Plasmodium falciparum
by: Preeyaporn Monatrakul, et al.
Published: (2018) -
Preventing antimalarial drug resistance with triple artemisinin-based combination therapies
by: Nguyen T.D.
Published: (2023) -
Triple artemisinin-based combination therapies for malaria: proceed with caution – Authors' reply
by: Rob W. van der Pluijm, et al.
Published: (2020)